Front cover of RSC Pharmaceutics

We are thrilled to announce that an article by a Chobotix team member Stanislav Chvíla has been selected for the front cover of the very first issue of a new journal RSC Pharmaceutics, published by the Royal Society of Chemistry. The work titled “A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model“, which is the result of a long-standing collaboration with the neurosteroids research group of Dr Eva Kudová from IOCB, reports on a novel approach to conducting in vivo studies with poorly soluble drugs, using nanosuspensions stabilised by phospholipids instead of solubilisation techniques that rely on DMSO or cyclodextrins. Keeping pace with current trends, the cover page graphics was created with the help of generative AI.